To print: Select File and then Print from your browser's menu
---------------------------------------------------------------------------------------
Title: FDA Approves Rabeprazole for Short-Term Treatment of GERD in Adolescents
URL: http://www.pslgroup.com/dg/224B22.htm
Doctor's Guide
July 1, 2008

WOODCLIFF LAKE, NJ -- July 1, 2008 -- The US Food and Drug Administration (FDA) has approved rabeprazole sodium (Aciphex) for the short-term (up to 8 weeks) treatment of gastro-oesophageal reflux disease (GERD) in adolescents aged 12 years and older.

Rabeprazole is classified as a proton pump inhibitor that effectively suppresses gastric acid secretion while inhibiting enzyme activity during the last phase of stomach acid secretion.

The approval was based on a 12-week, multicentre, open-label, randomised, parallel-group study of 111 adolescents with GERD. In this study, rabeprazole was well tolerated in adolescent subjects, with a safety profile similar to that in adults. The adverse events reported without regard to relationship to rabeprazole that occurred in >2% of 111 patients included headache (9.9%), diarrhoea (4.5%), nausea (4.5%), vomiting (3.6%), and abdominal pain (3.6%).

Efficacy results demonstrated that once-daily treatment with rabeprazole 20 mg for 8 weeks reduced the severity and frequency of GERD symptoms compared with symptoms prior to treatment.


SOURCE: Eisai Co., Ltd.

---------------------------------------------------------------------------------------------
Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.
---------------------------------------------------------------------------------------------
This news story was printed from *Doctor's Guide to the Internet*
located at http://www.docguide.com
---------------------------------------------------------------------------------------

Return to News Story Page

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.
All contents Copyright (c) 1998 P\S\L Consulting Group Inc.
All rights reserved.